Medtronic Cardiac Ablation Solutions
Clinical trials sponsored by Medtronic Cardiac Ablation Solutions, explained in plain language.
Division of Medtronic making devices for cardiac ablation procedures.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart device registry tracks Real-World results for 1,950 AFib patients Results expected Oct 2026 (estimated)
- New heart catheter aims to stop dangerous rhythms in their tracks Results expected Nov 2026 (estimated)
- New catheter aims to tame irregular heartbeat Results expected Mar 2027 (estimated)
- New device aims to zap away atrial fibrillation Results expected Mar 2027 (estimated)
- New heart procedure tracked for 3 years in 580 patients Results expected Apr 2027 (estimated)